Imaging and Radiation Oncology Core (IROC) Group
Imaging and Radiation Oncology Core (IROC) Group
批准号:
9919498
负责人:
MICHAEL V KNOPP
金额:
$925.79万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-05-26 至 2025-02-28
关键词:
AftercareAmerican College of RadiologyClinical ManagementClinical TrialsClinical Trials Cooperative GroupClinical Trials DesignCommunicationCommunication ProgramsConsultationsCredentialingDataData CollectionData SetDevelopmentDigital Imaging and Communications in MedicineDiseaseEnsureFundingGrantImageInformation SystemsInformation TechnologyInfrastructureLeadershipLocationMalignant NeoplasmsMethodologyModalityModernizationNational Cancer InstituteNational Clinical Trials NetworkOhioOncology GroupOutcomePatient imagingPatientsPhiladelphiaPrincipal InvestigatorProceduresProcessRadiation OncologyRadiation therapyRecommendationRhode IslandSecureServicesSiteSubgroupTechnical ExpertiseTechnologyTimeUncertaintyUniversitiesVisionWashingtonWorkcancer clinical trialclinical imagingclinical trial analysisdata acquisitiondata managementeffective therapymemberoperationorganizational structureprogramsprospectiveprotocol developmentquality assurancetherapy outcometooltrial design
中文摘要
成像和放射肿瘤学(IROC)组的主要目标是
提供科学和技术专门知识,
成像和放射治疗的质量保证(QA)和图像数据管理
(RT)在国家临床试验网络(NCTN)进行的适用试验中
计划和其他NCI资助的临床试验组(NCORP和ETCTN)。物理
IROC QA中心分布在4个主要地点,并在行政上进行组织
美国放射学会(ACR)QA中心包括IROC
休斯顿、俄亥俄州、罗得岛和费城。先进
位于圣路易斯华盛顿大学的技术质量保证中心(ATC)将提供
根据需要向IROC提供专业知识和咨询服务。IROC利用
现有的基础设施和专业知识,目前提供服务的质量保证中心,
NCI的临床试验项目。工作流程、流程和信息系统已经
考虑到综合构想中的最佳做法和标准,
在NCI的临床试验中。成像和RT之间的相互依赖性是
协同消除重复服务和优化高效和有效
工作流程。IROC的一个主要优势是开发一致的标准
NCTN、NCORP和ETCTN所有成像和RT方面的操作程序
(NCI组),并促进成像和RT患者病例数据集的无缝流动
跨网络。IROC的组织结构允许提供广泛的
成像和RT QA服务,包括研究中心资格认证;试验设计支持;
资格认证;数据管理(治疗前和治疗后病例审查);和病例
审查.使用信息技术基础设施,协调IROC
服务,数据收集,评估和管理NCI集团的临床
审判IROC实施的计划可确保一致的高质量成像和RT
在NCTN参与研究中心的规划/交付。IROC成员与
NCI、NCI组和每个网络组内的疾病/模式委员会,
提供最佳和有效的成像和RT核心服务。IROC集团将
分析前瞻性/回顾性获得的QA数据及其可能的相关性
临床试验结果,以更好地确定和优先考虑适当的QA活动
最大限度地提高临床试验的效益。
英文摘要
The primary objective of the Imaging and Radiation Oncology (IROC) Group is to
provide scientific and technical expertise for incorporation of appropriate, integrated
quality Assurance (QA) and image data management for both imaging and radiotherapy
(RT) in applicable trials conducted by the National Clinical Trials Network (NCTN)
Program and other NCI funded clinical trial groups (NCORP and ETCTN). The physical
IROC QA Centers are distributed in 4 main locations and are administratively organized
through the American College of Radiology (ACR). The QA Centers include IROC
Houston, IROC Ohio, IROC Rhode Island, and IROC Philadelphia. The Advanced
Technology QA Center (ATC) located at Washington University, St. Louis will provide
their expertise and consultation services to IROC as needed. IROC capitalizes on
existing infrastructure and expertise at QA centers currently providing services to the
NCI’s clinical trial programs. Work flows, processes and information systems have been
enhanced taking into account the best practices and standards in an integrated vision
across NCI’s clinical trials. The interdependencies between imaging and RT are
synergized eliminating duplication of services and optimizing efficient and effective
workflows. A major strength of IROC is the development of consistent standard
operating procedures for all imaging and RT aspects of the NCTN, NCORP and ETCTN
(NCI Groups) and to facilitate a seamless flow of imaging and RT patient case datasets
across the networks. IROC’s organizational structure allows the delivery of a broad array
of imaging and RT QA services including Site Qualification; Trial Design Support;
Credentialing; Data Management (Pre- and Post-treatment Case Review); and Case
Review. An information technology infrastructure is used that harmonizes IROC
services, data collection, assessment and management for the NCI Groups’ clinical
trials. IROC implements programs that assure consistent high quality imaging and RT
planning/delivery across the NCTN participating sites. IROC members collaborate with
the NCI, NCI Groups, and disease/modality committees within each Network Group to
provide an optimum and effective imaging and RT core service. The IROC Group will
analyze QA data obtained prospectively/retrospectively and the correlation it might have
with clinical trial outcomes to better determine and prioritize appropriate QA activities
that maximize their benefit to clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validating Low FDG Dose PET/CT compared to current Standard of Care Dose PET/CT
-
批准号:9086293
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2015
-
负责人:MICHAEL V KNOPP
-
依托单位:
Imaging and Radiation Oncology Core (IROC) Group
-
批准号:10582574
-
项目类别:
-
资助金额:$1020.33万
-
财政年份:2014
-
负责人:MICHAEL V KNOPP
-
依托单位:
IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trials
-
批准号:10544595
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2014
-
负责人:MICHAEL V KNOPP
-
依托单位:
Imaging and Radiation Oncology Core (IROC) Group
-
批准号:10376892
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2014
-
负责人:MICHAEL V KNOPP
-
依托单位:
Imaging and Radiation Oncology Core (IROC) Group
-
批准号:10117815
-
项目类别:
-
资助金额:$9.26万
-
财政年份:2014
-
负责人:MICHAEL V KNOPP
-
依托单位:
Imaging and Radiation Oncology Core (IROC) Group
-
批准号:10361187
-
项目类别:
-
资助金额:$938.17万
-
财政年份:2014
-
负责人:MICHAEL V KNOPP
-
依托单位:
海外基金